Achillion Pharmaceuticals (ACHN) PT Lowered to $4 at Baird as J&J Walks on Hep C Deal
Tweet Send to a Friend
Baird analyst Brian Skorney lowered his price target on Achillion Pharmaceuticals (NASDAQ: ACHN) to $4.00 (from $5.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
